Products and Services
Products and Services
Active Pharmaceutical Ingredients
Product Name
CAS Number
Specification
DMF
CEP
Status
CN
PV
Bimetinib
606143-89-9
Q2 2025
Q4 2024
Cabozantinib
849217-68-1
Q2 2025
Q4 2024
Carmatinib
1029712-80-8
Q1 2026
Q3 2025
Darolutamide
1297538-32-9
Q1 2026
Q3 2025
Deutetrabenazine
1609392-27-9
Q1 2026
Q3 2025
Encofeni
1269440-29-0
Q3 2025
Q1 2025
Ficlatuzumab
936091-26-8
Q1 2026
Q3 2025
Gilteritinib
1254053-43-4
Q1 2026
Q3 2025
Lorlatinib
1454846-35-5
Q1 2026
Q3 2025
Osimertinib
1421373-66-1
Q2 2025
Q4 2024
Paxertinib
937272-79-2
Q3 2025
Q1 2025
Ribociclib
1211441-98-3
Q2 2025
Q4 2024
Lutetixitinib
1792180-81-4
Q2 2025
Q4 2024
Simetinib
606143-52-6
Q1 2026
Q3 2025
Tepotinib
1100598-32-0
Q1 2026
Q3 2025
Dabrafenib mesylate
1187431-43-1
Q2 2025
Q4 2024
Tofacitinib
937263-43-9
Q2 2025
Q4 2024
Upadacitinib
1310726-60-3
Q3 2025
Q1 2025
Elcatone
2216712-66-0
Q2 2025
Q4 2024
Ivacaftor
873054-44-5
Q2 2025
Q4 2024
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
